Skip to content

A Closed-Loop Human-Computer Interaction System and Application aimed at the Diagnosis and Treatment of Mental Diseases

A Closed-Loop Human-Computer Interaction System and Application aimed at the Diagnosis and Treatment of Mental Diseases

Status
Active, not recruiting
Phases
Early Phase 1
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR2400085831
Enrollment
Unknown
Registered
2024-06-19
Start date
2024-06-24
Completion date
Unknown
Last updated
2024-07-08

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Major Depressive Disorder

Interventions

transcranial alternating current stimulation (tACS) group:The tACS group was given tACS real stimulation for 2 weeks, 5 times a week, and each stimulation lasted 20 minutes.
temporal interference (TI) group:The TI group was given TI real stimulation for 2 weeks, 5 times a week, and each stimulation lasted 20 minutes.
sham group:The sham group was given sham stimulation for 2 weeks, 5 times a week, and each stimulation lasted 20 minutes.

Sponsors

Tianjin Anding Hospital
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 50 Years

Inclusion criteria

Inclusion criteria: (1) Meet the diagnostic criteria for "depressive disorders" in the Diagnostic and Statistical Manual of Mental Disorders (DSM-5), and all patients must have their diagnosis independently confirmed by at least two attending physicians or psychiatrists of higher level, and are currently in a depressive episode; (2) Age 18-50 years old; (3) Gender is not limited; (4) Junior high school education or above; (5) No antidepressant medication used at least 2 weeks before enrollment; (6) Patients can read and understand the informed consent form, self-assessment scale, etc.; (7) Patients or their family members agree to participate in this study and sign the informed consent form.

Exclusion criteria

Exclusion criteria: (1) Those with a history of psychiatric genetic disorders consistent with DSM-5, or a diagnosis of other mental illnesses other than "depressive disorders"; (2) Those with craniocerebral trauma or a history of coma; (3) Those with organic brain or severe physical diseases; (4) Those with a history of epileptic seizures or a family history of epilepsy; (5) Those with obvious suicidal or impulsive behavior; (6) Those who have received physical therapy such as electroconvulsive therapy and transcranial magnetic stimulation therapy in the past six months; (7) Those with a history of alcoholism or use of other psychoactive substances; (8) Those who are currently participating in other drug clinical trials; (9) Any factors that prevent participants from providing informed consent or participating in the study.

Design outcomes

Primary

MeasureTime frame
Hamilton Depression Rating Scale (HAMD-17) score;

Secondary

MeasureTime frame
Hamilton Anxiety Scale (HAMA) score;Young Mania Rating Scale (YMRS) score;Patient Health Questionnaire-9 (PHQ-9) score;Generalized Anxiety Disorder (GAD-7) score;Hypomania Checklist (HCL-32) score;

Countries

China

Contacts

Public ContactShenLi

Tianjin Anding Hospital

lishen@tmu.edu.cn+86 22 8818 8875

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026